FIELD: chemistry.
SUBSTANCE: invention refers to of serotonin receptor 5-NT6 antagonists, simultaneously regulating calcium ions homeostasis in cells, representing substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole of general formula I, its pharmaceutically acceptable salt and/or hydrate. In general formula I 
where: R1 is amides substitute selected from optionally substituted C1-C5 alkyl; R2i represents one or number of identical or various substitutes selected from hydrogen, halogen, C1-C3 alkyl, CF3, OCF3; Ar represents halogen unsubstituted or substituted C1-C6 alkyl, C1-C6 alkoxy, phenyl substituted with amides or trifluoromethyl or optionally substituted aromatic hexamerous heterocycle containing 1-2 nitrogen atoms per one cycle, W represents ethyl group-CH2CH2 - vinyl group or ethynyl group. Invention also concerns new compounds selected from group of compounds of formula 1, methods of production thereof, pharmaceutical compositions and methods of their use.
EFFECT: production of composition that simultaneously regulates calcium ions homeostasis in cells.
34 cl, 7 dwg, 4 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| LIGANDS OF ALPHA-ADRENOCEPTORS, DOPAMINE, HISTAMINE, IMIDAZOLINE AND SEROTONIN RECEPTORS AND USE THEREOF | 2008 |
|
RU2407744C2 |
| HISTAMINE RECEPTOR BLOCKERS FOR PHARMACEUTICAL COMPOSITIONS OF ANTIALLERGIC AND AUTOIMMUNE EFFECT | 2007 |
|
RU2339637C1 |
| SUBSTITUTED 2,3,4,5-TETRAHYDRO-1N-PYRIDO[4,3-b]INDOLES, METHOD OF OBTAINING THEM AND USE | 2007 |
|
RU2338745C1 |
| SUBSTITUTED AZEPINO[4,3-b]INDOLES, PHARMACEUTICAL COMPOSITION, METHOD FOR THEIR PREPARING AND USING | 2006 |
|
RU2317989C1 |
| SUBSTITUTED 8-SULPHONYL-2,3,4,5-TETRAHYDRO-1H-GAMMA-CARBOLINES, LIGANDS, PHARMACEUTICAL COMPOSITION, SYNTHESIS METHOD AND USE THEREOF | 2009 |
|
RU2404180C1 |
| SUBSTITUTED PYRROLO[4,3-b]INDOLES, COMBINATORY AND FOCUSED LIBRARY, PHARMACEUTICAL COMPOSITION, METHODS FOR THEIR PREPARING AND USING | 2006 |
|
RU2320662C1 |
| PHARMACEUTICAL COMPOSITION, METHOD FOR ITS PREPARING AND USING | 2006 |
|
RU2303597C1 |
| SUBSTITUTED 3,4,12,12A-TETRAHYDRO-1H-[1,4]OXAZINO[3,4-C]PYRIDO[2,1-F][1,2,4]TRIAZINE-6,8-DIONE, PHARMACEUTICAL COMPOSITION, METHODS FOR PRODUCTION AND USE THEREOF | 2019 |
|
RU2720305C1 |
| NORADRENERGIC AND SPECIFICALLY SEROTONERGIC ANXIOLYTIC AND ANTIDEPRESSANT, ITS PRODUCTION AND APPLICATION METHOD | 2020 |
|
RU2775772C2 |
| DERIVATIVES OF HYDROGENATED PYRIDO[4,3-B]INDOLES, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF PATIENT TREATMENT | 1995 |
|
RU2140417C1 |
